HUONS CO., LTD. Logo

HUONS CO., LTD.

Develops and manufactures pharmaceuticals, medical solutions, and medical devices.

243070 | KO

Overview

Corporate Details

ISIN(s):
KR7243070000
LEI:
Country:
South Korea
Address:
경기도 성남시 수정구 창업로 17 판교 아이스퀘어 A동 8층, 성남시

Description

HUONS CO., LTD. is an integrated pharmaceutical and healthcare company founded in 1965. The company develops and manufactures a wide range of finished pharmaceutical products, medical solutions, and medical devices under cGMP standards. It was a pioneer in its domestic market, developing the first plastic ampule injections and local anesthetics. The company's research and development efforts focus on key therapeutic areas including ophthalmology, osteoarthritis, dermatology, wellness, and Central Nervous System (CNS) disorders. Its diversified portfolio also extends to bio products, eye drops, cosmetics, and health functional foods, aiming to provide comprehensive healthcare solutions.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.
Quick Filters:

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2020-11-12 00:00
[기재정정]주요사항보고서(전환사채권발행결정)
Korean 54.9 KB
2020-11-12 00:00
분기보고서 (2020.09)
Korean 1.3 MB
2020-11-11 00:00
주요사항보고서(전환사채권발행결정)
Korean 50.7 KB
2020-10-29 00:00
투자판단관련주요경영사항(HU024 점안제의 국내 임상시험계획 승인)
Korean 8.6 KB
2020-09-10 00:00
기타경영사항(특허권취득)(자율공시)(사이클로스포린 및 트레할로스를 포함하는 안과용 조성물)
Korean 5.8 KB
2020-09-09 00:00
기업설명회(IR)개최
Korean 7.3 KB
2020-08-18 00:00
기업설명회(IR)개최
Korean 7.3 KB
2020-08-14 00:00
주요사항보고서(자기주식취득신탁계약체결결정)
Korean 27.1 KB
2020-08-13 00:00
반기보고서 (2020.06)
Korean 1.3 MB
2020-07-01 00:00
투자판단관련주요경영사항(복합점안제(HU007) 임상시험 3상 종료)
Korean 9.6 KB
2020-07-01 00:00
투자판단관련주요경영사항(복합점안제(HU007)의 품목허가 신청)
Korean 9.0 KB
2020-06-10 00:00
기업설명회(IR)개최
Korean 7.7 KB
2020-06-04 00:00
투자판단관련주요경영사항(HU007(나노복합점안제)의 독일 임상시험계획 승인)
Korean 8.9 KB
2020-05-26 00:00
기업설명회(IR)개최
Korean 7.3 KB
2020-05-13 00:00
분기보고서 (2020.03)
Korean 1.2 MB

Automate Your Workflow. Get a real-time feed of all HUONS CO., LTD. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for HUONS CO., LTD.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for HUONS CO., LTD. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

4BASEBIO PLC Logo
Manufactures GMP-grade synthetic DNA for next-generation therapeutics and vaccines.
United Kingdom
4BB
4D Molecular Therapeutics, Inc. Logo
Develops genetic medicines using AAV vectors for ophthalmology and pulmonology diseases.
United States of America
FDMT
4SC AG Logo
Biopharmaceutical company with no products under development or operational business.
Germany
VSC
60 DEGREES PHARMACEUTICALS, INC. Logo
Develops and commercializes medicines for infectious diseases, focusing on tropical illnesses.
United States of America
SXTP
89bio, Inc. Logo
Clinical-stage biopharma developing therapies for liver and cardiometabolic diseases.
United States of America
ETNB
Aardvark Therapeutics, Inc. Logo
Clinical-stage biopharma developing therapeutics for hunger and metabolic diseases.
United States of America
AARD
ABBOTT LABORATORIES Logo
Global healthcare company in medical devices, diagnostics, nutrition & pharmaceuticals.
United States of America
ABT
AbbVie Inc. Logo
A research-based biopharmaceutical company developing and manufacturing medicines.
United States of America
ABBV
AbCellera Biologics Inc. Logo
Discovers and develops antibody-based therapeutics using a proprietary platform.
United States of America
ABCL
Develops antibody-based therapeutics using CAR-T, NEST, and AffiMab platforms.
South Korea
174900

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.